On Monday, Shares of Fidelity National Financial, Inc. (NYSE:FNF), gained 1.45% to $36.99.
Black Knight Financial Services, will release third quarter 2015 earnings after the close of regular market trading on Tuesday, October 27, 2015. A conference call to discuss its results will follow at 5:00 p.m. Eastern Time that same day.
Black Knight Financial Services, Inc. (BKFS), a Fidelity National Financial (FNF) company, is the mortgage and finance industries’ leading provider of integrated technology, data and analytics solutions that facilitate and automate many of the business processes across the mortgage lifecycle.
Fidelity National Financial, Inc., together with its auxiliaries, provides title insurance, technology, and transaction services to the real estate and mortgage industries in the United States. It operates through Title, BKFS, and Restaurant Group segments.
Shares of Kosmos Energy Ltd (NYSE:KOS), inclined 3.35% to $6.17, during its last trading session.
Kosmos Energy, declared the following plan for its third quarter 2015 results:
- Earnings Release: Monday, November 2, 2015, pre-market via Business Wire and the Company’s.
- Conference Call: Monday, November 2, 2015, at 11:00 a.m. EST.
Kosmos Energy Ltd. explores for and produces oil and gas in Africa, Europe, and South America. Its asset portfolio comprises production and other development projects in offshore Ghana, in addition to exploration licenses with hydrocarbon potential in offshore Ireland, Mauritania, Morocco, Senegal, and Suriname. The company was founded in 2003 and is based in Hamilton, Bermuda.
At the end of Monday’s trade, Shares of Depomed Inc (NASDAQ:DEPO), gained 0.45% to $19.91.
Depomed, issued the following statement regarding a report by Institutional Shareholder Services’ (“ISS”) on Horizon Pharma plc’s (HZNP) solicitation to call two special meetings of Depomed’s shareholders.
The ISS recommendation relates only to calling the Special Meetings, and ISS has not made any recommendation regarding Horizon’s proposal concerning directors or its exchange offer. In its report ISS states, “…ISS explicitly reserves judgment on the advisability of Horizon’s offer until shareholders have the benefit of additional information about the Nucynta relaunch, and are presented with the opportunity to vote on that question directly.”
Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the administration of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; and Lazanda (fentanyl) nasal spray, an intranasal fentanyl drug used to manage breakthrough pain in adults.
Finally, Synthesis Energy Systems, Inc. (NASDAQ:SYMX), ended its last trade with 1.17% gain, and closed at $0.951.
Synthesis Energy Systems, declared that it has successfully extended its 20 million yuan (U.S. $3.1 million) working capital loan at SES’s Zao Zhuang New Gas Company Joint Venture facility (ZZ) in Zao Zhuang City, Shandong Province, China. The extension is for 11 months and is now due on August 22, 2016.
“This is an important step as we continue to make progress with our new ZZ partner, Rui Feng/Saikong, towards positioning the ZZ facility for profitability by repurposing the facility to produce acetic and propionic acid,” said Donald Huang, Managing Director of SES China operations. “Concluding this loan extension demonstrates the local support we have for the repurposing and expansion project there. Our attention will now be focused on the work required to secure the necessary amendments to the existing government approvals in addition to other financial and project planning steps required to start construction.”
Synthesis Energy Systems, Inc., an energy and gasification technology company, together with its auxiliaries, provides proprietary gasification technology systems and solutions to the energy and chemical industries worldwide. It offers U-GAS fluidized bed gasification technology to convert low quality coals, such as lignite, coal wastes, municipal wastes, and agricultural waste biomass to high value products, such as electric power, transportation fuels, and substitute natural gas fuel for direct reduction iron, steel making, and other products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.